மருந்து ஆராய்ச்சி அலகு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Can We Fix the Body’s Dysmetabolic State?
Copy link
By Lina Zeldovich
Copy link
WHY YOU SHOULD CARE
It s a condition that increases the risk of diabetes and more. Now hope might be around the corner.
By Lina Zeldovich
February24, 2021
An epidemic of obesity is leading to multiple diseases that share as their basis a problem called the dysmetabolic state.
This condition increases the risk of diabetes, cardiovascular disease and a serious, progressive form of nonalcoholic fatty liver disease known as nonalcoholic steatohepatitis, or NASH.
Now scientists believe they may have found a way to fight back.
It’s no secret that obesity, diabetes and heart disease are among the most devastating illnesses of the developed world. But while many health care professionals used to view them as separate, stand-alone conditions, there’s now a growing awareness that the three are tightly connected, caused by a shared problem called the dysmetabolic ....

United States , Jeffrey Pfefferkorn , Medicine Research Unit , Pfizer Internal Medicine Research Unit , Drug Administration Or European Medicines Agency , Discovery Development , American Liver Foundation , University Of Oslo , Internal Medicine Research , Vice President , Internal Medicine Research Unit , Dysmetabolic State , American Liver , Tom Hemming Karlsen , European Association , Drug Administration , European Medicines Agency , ஒன்றுபட்டது மாநிலங்களில் , ஜெஃப்ரி பிபெப்பேற்க்கொர்ன் , மருந்து ஆராய்ச்சி அலகு , ஃபைசர் உள் மருந்து ஆராய்ச்சி அலகு , கண்டுபிடிப்பு வளர்ச்சி , அமெரிக்கன் கல்லீரல் அடித்தளம் , பல்கலைக்கழகம் ஆஃப் ஒசிலோ , உள் மருந்து ஆராய்ச்சி , துணை ப்ரெஸிடெஂட் ,